BioCentury This Week

BioCentury This Week

Por: BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
332 episodios disponibles

Latest episodes of the podcast BioCentury This Week

Ep. 322 - Takeaways from BioCentury Grand Rounds Europe 23/09/2025
Ep. 321 - Pfizer’s Obesity Play & U.K. in Focus 22/09/2025
Ep. 320 - U.K. Biotech, U.S.-China, Insmed 15/09/2025
Ep. 319 - David Baltimore’s Legacy, Atlas Fund, MASH Pipeline and more 08/09/2025
Ep. 318 - Newco Takes on CV Risk. Plus: Disrupting Vaccines 02/09/2025
Ep. 317 - Biotech IPOs, FDA-Stealth & Patent Threat 25/08/2025
Ep. 316 - Trends in Pharma Deals 18/08/2025
Ep. 315 - China Speed: Data, Deals, First in Class 13/08/2025
Ep. 314 - Prasad, Lilly Obesity, Acadia & Biosecure 11/08/2025
Ep. 313 - Lessons from FDA's Prasad. Plus: What's next for Novo, Bayer 04/08/2025
Ep. 312 - Biotech Progress Report 29/07/2025
Ep. 311 - The Asia Deals Landscape, U.K. Biotech & More 28/07/2025
Ep. 310 - Sarepta & What's Next for Gene Therapy. Plus: Leading FDA's CDER 21/07/2025
Ep. 309 - 3Q Markets Preview; Quantum Computing; Makary’s First 100 Days 14/07/2025
Ep. 308 - Grand Rounds - Europe Preview 09/07/2025
Ep. 307 - How Cancer Regulation is — and isn’t — Changing at FDA 08/07/2025
Ep. 306 - Treg Inflection Point; Biotech's Next Big Story; Tax Bill Consequences 07/07/2025
Ep. 305 - FDA's Future; In Vivo CAR T Plays; Psychedelics; CDK2 30/06/2025
Ep. 304 - Syncona Reshapes Fund; Lilly's $1B Verve Bet; FDA's 2-Track Future 23/06/2025
Ep. 303 - Gene Therapy Safety, Amylin in Obesity & FDA's Future 16/06/2025
1 2 3 ... 17 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA